Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parasitic Diseases

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 94 articles:
HTML format
Text format



Single Articles


    March 2017
  1. MOREIRA VR, de Jesus LC, Soares RP, Silva LD, et al
    Glucantime(R) causes oxidative stress-derived DNA damage in Balb/c mice infected by Leishmania (Leishmania) infantum.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.02360.
    PubMed     Text format     Abstract available


  2. MARTIN-MONTES A, Plano D, Martin-Escolano R, Alcolea V, et al
    A library of seleno-compounds and Leishmania species: Rising evidences towards novel agents.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.02546.
    PubMed     Text format     Abstract available


  3. PHOLWAT S, Liu J, Stroup S, Jacob S, et al
    The Malaria TaqMan Array Card: 87 assays for Plasmodium falciparum drug resistance, speciation, and genotyping in a single reaction.
    Antimicrob Agents Chemother. 2017 Mar 6. pii: AAC.00110.
    PubMed     Text format     Abstract available


  4. VALE N, Gouveia MJ, Rinaldi G, Brindley PJ, et al
    Praziquantel for schistosomiasis, single drug revisited metabolism, mode of action and resistance.
    Antimicrob Agents Chemother. 2017 Mar 6. pii: AAC.02582.
    PubMed     Text format     Abstract available


    February 2017
  5. ABENGOZAR MA, Cebrian R, Saugar JM, Garate T, et al
    The enterocin AS-48 as an evidence for the use of bacteriocins as new leishmanicidal agents.
    Antimicrob Agents Chemother. 2017 Feb 6. pii: AAC.02288.
    PubMed     Text format     Abstract available


  6. DA COSTA-SILVA TA, Galisteo AJ Jr, Lauletta Lindoso JA, Barbosa LR, et al
    Nanoliposomal Buparvaquone Immunomodulates Leishmania (L.) infantum-infected Macrophages and is Highly Effective in Murine Model.
    Antimicrob Agents Chemother. 2017 Feb 6. pii: AAC.02297.
    PubMed     Text format     Abstract available


    January 2017
  7. CARIDHA D, Parriot S, Hudson TH, Lang T, et al
    Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost Effective Drug Screen as Part of a Tiered In vivo Screening Paradigm for Development of Drugs to Treat Cutaneous Leishmaniasis.
    Antimicrob Agents Chemother. 2017 Jan 30. pii: AAC.02048.
    PubMed     Text format     Abstract available


  8. THUY-NHIEN N, Tuyen NK, Tong NT, Vy T, et al
    K13-Propeller Mutations in Plasmodium falciparum Populations in Malaria Endemic Regions of Vietnam from 2009 to 2016.
    Antimicrob Agents Chemother. 2017 Jan 30. pii: AAC.01578.
    PubMed     Text format     Abstract available


  9. SUTHERLAND CJ, Lansdell P, Sanders M, Muwanguzi J, et al
    Pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria given artemether-lumefantrine in the UK.
    Antimicrob Agents Chemother. 2017 Jan 30. pii: AAC.02382.
    PubMed     Text format     Abstract available


  10. WALKER LA, Sullivan DJ Jr
    Impact of extended artesunate duration on parasitological outcome in a cytocidal murine malaria model.
    Antimicrob Agents Chemother. 2017 Jan 17. pii: AAC.02499.
    PubMed     Text format     Abstract available


  11. LOPEZ-ARENCIBIA A, Martin-Navarro C, Sifaoui I, Reyes-Batlle M, et al
    Perifosine mechanisms of action in Leishmania spp.
    Antimicrob Agents Chemother. 2017 Jan 17. pii: AAC.02127.
    PubMed     Text format     Abstract available


  12. KONIORDOU M, Patterson S, Wyllie S, Seifert K, et al
    Snapshot profiling of anti-leishmanial potency of lead compounds and drug candidates against intracellular L. donovani amastigotes with focus on human derived host cells.
    Antimicrob Agents Chemother. 2017 Jan 9. pii: AAC.01228.
    PubMed     Text format     Abstract available


  13. GENDROT M, Diawara S, Madamet M, Kounta MB, et al
    Association between Polymorphisms in pfmdr6 Gene and Ex Vivo Susceptibility to Quinine in Plasmodium falciparum Parasites from Dakar, Senegal.
    Antimicrob Agents Chemother. 2017 Jan 4. pii: AAC.01183.
    PubMed     Text format     Abstract available


    December 2016
  14. TIWARI B, Pahuja R, Kumar P, Rath SK, et al
    Nanotized Curcumin and Miltefosine, a Potential Combination for the Treatment of Experimental Visceral Leishmaniasis.
    Antimicrob Agents Chemother. 2016 Dec 28. pii: AAC.01169.
    PubMed     Text format     Abstract available


  15. CASTRO MD, Gomez MA, Kip AE, Cossio A, et al
    Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis.
    Antimicrob Agents Chemother. 2016 Dec 12. pii: AAC.02198.
    PubMed     Text format     Abstract available


  16. ZENG W, Bai Y, Wang M, Wang Z, et al
    Significant Divergence in Sensitivity to Antimalarial Drugs between Neighboring Plasmodium falciparum Populations along the Eastern Border of Myanmar.
    Antimicrob Agents Chemother. 2016 Dec 5. pii: AAC.01689.
    PubMed     Text format     Abstract available


    November 2016
  17. WANG Y, Yang F, Xue J, Zhou X, et al
    Anti-Schistosomiasis liver fibrosis effects of chlorogenic acid through IL-13/miR-21/Smad7 signaling interactions in vivo and in vitro.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01347.
    PubMed     Text format     Abstract available


  18. TRAN HT, White NJ, Nguyen TT, Nhu HT, et al
    Estimation of the in-vivo minimum inhibitory concentration of cipargamin in uncomplicated Plasmodium falciparum malaria.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01940.
    PubMed     Text format     Abstract available


  19. SONOIKI E, Nsanzabana C, Legac J, Sindhe KM, et al
    Altered Plasmodium falciparum sensitivity to the antiretroviral protease inhibitor lopinavir associated with polymorphisms in pfmdr1.
    Antimicrob Agents Chemother. 2016 Nov 7. pii: AAC.01949.
    PubMed     Text format     Abstract available


    October 2016
  20. GUERRA M, Neres R, Salgueiro P, Mendes C, et al
    Plasmodium falciparum genetic diversity of continental Equatorial Guinea before and after introduction of Artemisinin based Combination Therapy.
    Antimicrob Agents Chemother. 2016 Oct 24. pii: AAC.02556.
    PubMed     Text format     Abstract available


    September 2016
  21. CHANG ZW, Malleret B, Russell B, Renia L, et al
    An ex-vivo maturation assay for testing antimalarial sensitivity of rodent malaria parasites.
    Antimicrob Agents Chemother. 2016 Sep 6. pii: AAC.01292.
    PubMed     Text format     Abstract available


  22. ANDRADE-NETO VV, Cunha-Junior EF, Canto-Cavalheiro MM, Atella GC, et al
    Antileishmanial activity of ezetimibe: inhibition of sterol biosynthesis, in vitro synergy with azoles and efficacious in experimental cutaneous leishmaniasis.
    Antimicrob Agents Chemother. 2016 Sep 6. pii: AAC.01545.
    PubMed     Text format     Abstract available


  23. SIRIWARDANA A, Iyengar K, Roepe PD
    Endoperoxide Drug Cross Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed Clearance Phenotype.
    Antimicrob Agents Chemother. 2016 Sep 6. pii: AAC.00857.
    PubMed     Text format     Abstract available


    August 2016
  24. SAHA S, Acharya C, Pal U, Roy Chowdhury S, et al
    A novel spirooxindole derivative inhibits the growth of Leishmania donovani parasite both in vitro and in vivo by targeting type IB topoisomerase.
    Antimicrob Agents Chemother. 2016 Aug 8. pii: AAC.00352.
    PubMed     Text format     Abstract available


    July 2016
  25. DAVIS MI, Patrick S, Blanding WM, Dwivedi V, et al
    Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Anti-parasitic Activity.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00914.
    PubMed     Text format     Abstract available


  26. GARCIA-GARCIA V, Oldfield E, Benaim G
    Inhibition of Leishmania mexicana Growth by the Tuberculosis Drug SQ109.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00945.
    PubMed     Text format     Abstract available


  27. DE COZAR C, Caballero I, Colmenarejo G, Sanz LM, et al
    Development of a novel high density [3H]-hypoxanthine scintillation proximity assay to assess Plasmodium falciparum growth.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00433.
    PubMed     Text format     Abstract available


  28. NANKABIRWA JI, Conrad MD, Legac J, Tukwasibwe S, et al
    Intermittent preventive treatment with dihydroartemisinin-piperaquine in Ugandan schoolchildren selects for Plasmodium falciparum transporter polymorphisms that modify drug sensitivity.
    Antimicrob Agents Chemother. 2016 Jul 11. pii: AAC.00920.
    PubMed     Text format     Abstract available


    June 2016
  29. TEJERA NEVADO P, Bifeld E, Hohn K, Clos J, et al
    A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum.
    Antimicrob Agents Chemother. 2016 Jun 20. pii: AAC.00544.
    PubMed     Text format     Abstract available


  30. CHAVCHICH M, Van Breda K, Rowcliffe K, Diagana TT, et al
    The spiroindolone KAE609 does not induce dormant ring stages in Plasmodium falciparum parasites.
    Antimicrob Agents Chemother. 2016 Jun 13. pii: AAC.02838.
    PubMed     Text format     Abstract available


  31. ORTIZ D, Forquer I, Boitz J, Soysa R, et al
    Targeting the Cytochrome bc1 Complex of Leishmania Parasites for Discovery of Novel Drugs.
    Antimicrob Agents Chemother. 2016 Jun 13. pii: AAC.00850.
    PubMed     Text format     Abstract available


  32. SONOIKI E, Palencia A, Guo D, Ahyong V, et al
    Anti-malarial benzoxaboroles target P. falciparum leucyl-tRNA synthetase.
    Antimicrob Agents Chemother. 2016 Jun 6. pii: AAC.00820.
    PubMed     Text format     Abstract available


    May 2016
  33. PAUL AS, Moreira CK, Elsworth B, Allred DR, et al
    Extensive shared chemosensitivity between malaria and babesiosis blood-stage parasites.
    Antimicrob Agents Chemother. 2016 May 31. pii: AAC.00928.
    PubMed     Text format     Abstract available


  34. GENDROT M, Fall B, Madamet M, Fall M, et al
    Absence of association between polymorphisms in the RING E3 ubiquitin-protein ligase gene and ex vivo susceptibility to conventional antimalarial drugs in Plasmodium falciparum isolates from Dakar, Senegal.
    Antimicrob Agents Chemother. 2016 May 16. pii: AAC.03105.
    PubMed     Text format     Abstract available


  35. YANG T, Xie SC, Cao P, Giannangelo C, et al
    A comparison of the exposure time-dependence of the activities of synthetic ozonide antimalarials and dihydroartemisinin against K13 wildtype and mutant Plasmodium falciparum.
    Antimicrob Agents Chemother. 2016 May 9. pii: AAC.00574.
    PubMed     Text format     Abstract available


  36. ANDRADE JM, Baba EH, Machado-de-Avila RA, Chavez-Olortegui C, et al
    Silver and nitrate oppositely modulate antimony susceptibility through aquaglyceroporin 1 in Leishmania (Viannia) species.
    Antimicrob Agents Chemother. 2016 May 9. pii: AAC.00768.
    PubMed     Text format     Abstract available


    April 2016
  37. VACCHINA P, Norris-Mullins B, Abengozar MA, Viamontes CG, et al
    Multifactorial basis for in vitro acquisition of miltefosine resistance in Leishmania donovani: a genomic appraisal.
    Antimicrob Agents Chemother. 2016 Apr 25. pii: AAC.00478.
    PubMed     Text format     Abstract available


  38. ARNOLD MS, Engel JA, Chua MJ, Fisher GM, et al
    Adaption of the [3H]-hypoxanthine uptake assay for in vitro cultured Plasmodium knowlesi malaria parasites.
    Antimicrob Agents Chemother. 2016 Apr 25. pii: AAC.02948.
    PubMed     Text format     Abstract available


  39. DA CUNHA-JUNIOR EF, Martins TM, Canto-Cavalheiro MM, Marques PR, et al
    Preclinical studies of LQB-118: subacute toxicity and therapeutic evaluation in experimental visceral leishmaniasis.
    Antimicrob Agents Chemother. 2016 Apr 11. pii: AAC.01787.
    PubMed     Text format     Abstract available


  40. MCCARTHY JS, Marquart L, Sekuloski S, Trenholme K, et al
    Linking murine and human Plasmodium falciparum challenge models in a translational path for antimalarial drug development.
    Antimicrob Agents Chemother. 2016 Apr 4. pii: AAC.02883.
    PubMed     Text format     Abstract available


    March 2016
  41. PEREA A, Manzano JI, Castanys S, Gamarro F, et al
    LABCG2 transporter from the protozoan parasite Leishmania is involved in antimony resistance.
    Antimicrob Agents Chemother. 2016 Mar 28. pii: AAC.02813.
    PubMed     Text format     Abstract available


  42. TEGAZZINI D, Diaz R, Aguilar F, Pena I, et al
    A replicative in vitro assay for drug discovery against Leishmania donovani.
    Antimicrob Agents Chemother. 2016 Mar 28. pii: AAC.01781.
    PubMed     Text format     Abstract available


  43. MITA T, Culleton R, Takahashi N, Nakamura M, et al
    Little polymorphism at the K13 propeller locus in worldwide Plasmodium falciparum populations prior to the introduction of artemisinin combination therapies.
    Antimicrob Agents Chemother. 2016 Mar 21. pii: AAC.02370.
    PubMed     Text format     Abstract available


  44. KAPLUM V, Cogo J, Sangi DP, Ueda-Nakamura T, et al
    In vitro and in vivo activity of 2,3-diarylsubstituted quinoxaline derivatives in Leishmania amazonensis.
    Antimicrob Agents Chemother. 2016 Mar 21. pii: AAC.02582.
    PubMed     Text format     Abstract available


    February 2016
  45. ZEEMAN AM, Lakshminarayana SB, van der Werff N, Klooster EJ, et al
    PI4K is a prophylactic, but not radical curative target in Plasmodium vivax-type malaria parasites.
    Antimicrob Agents Chemother. 2016 Feb 29. pii: AAC.03080.
    PubMed     Text format     Abstract available


  46. RICE DR, Vacchina P, Norris-Mullins B, Morales MA, et al
    Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.
    Antimicrob Agents Chemother. 2016 Feb 29. pii: AAC.00410.
    PubMed     Text format     Abstract available


  47. LEANG R, Canavati SE, Khim N, Vestergaard LS, et al
    Efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in western Cambodia.
    Antimicrob Agents Chemother. 2016 Feb 29. pii: AAC.00039.
    PubMed     Text format     Abstract available


  48. DURIEU E, Prina E, Leclercq O, Oumata N, et al
    From drug screening to target deconvolution: A target-based drug discovery pipeline using Leishmania casein kinase 1 isoform 2 to identify compounds with anti-leishmanial activity.
    Antimicrob Agents Chemother. 2016 Feb 22. pii: AAC.00021.
    PubMed     Text format     Abstract available


  49. LEZAMA-DAVILA CM, McChesney JD, Bastos JK, Miranda MA, et al
    Development of a new antileishmanial preparation: Combined solamargine and solasonine heal cutaneous leishmaniasis through different immunochemical pathways.
    Antimicrob Agents Chemother. 2016 Feb 16. pii: AAC.02804.
    PubMed     Text format     Abstract available


  50. MALLICK S, Dutta A, Chaudhuri A, Mukherjee D, et al
    Successful therapy of murine visceral leishmaniasis with astrakurkurone, a triterpene isolated from mushroom Astraeus hygrometricus, involves the induction of protective cell mediated immunity and TLR9.
    Antimicrob Agents Chemother. 2016 Feb 16. pii: AAC.01943.
    PubMed     Text format     Abstract available


  51. MARR AK, Cen S, Hancock RE, McMaster WR, et al
    Identification of synthetic- and natural host defense peptides with leishmanicidal activity.
    Antimicrob Agents Chemother. 2016 Feb 16. pii: AAC.02328.
    PubMed     Text format     Abstract available


  52. JAVELLE E, Madamet M, Gaillard T, Velut G, et al
    Delayed P. falciparum Malaria after Doxycycline Prophylaxis, Central African Republic, 2015.
    Antimicrob Agents Chemother. 2016 Feb 8. pii: AAC.01858.
    PubMed     Text format     Abstract available


  53. CHERUIYOT AC, Auschwitz JM, Lee PJ, Yeda RA, et al
    Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Test using SYBR Green Assay for Field Samples with Varying Initial Parasitemia.
    Antimicrob Agents Chemother. 2016 Feb 8. pii: AAC.00527.
    PubMed     Text format     Abstract available


  54. HASTINGS IM, Kay K, Hodel EM
    Reply to "Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task".
    Antimicrob Agents Chemother. 2016;60:1173-4.
    PubMed     Text format    


  55. SIMPSON JA, McCaw J, Fowkes FJ
    Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task.
    Antimicrob Agents Chemother. 2016;60:1172.
    PubMed     Text format    


  56. SCHAD C, Baum U, Frank B, Dietzel U, et al
    Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.
    Antimicrob Agents Chemother. 2015;60:797-805.
    PubMed     Text format     Abstract available


    January 2016
  57. LUCANTONI L, Fidock DA, Avery VM
    A Luciferase-Based, High-Throughput Assay For Screening And Profiling Transmission-Blocking Compounds Against Plasmodium falciparum Gametocytes.
    Antimicrob Agents Chemother. 2016 Jan 19. pii: AAC.01949.
    PubMed     Text format     Abstract available


  58. BALAICH JN, Mathias DK, Torto B, Jackson BT, et al
    The non-artemisinin sesquiterpene lactones parthenin and parthenolide block Plasmodium falciparum sexual stage transmission.
    Antimicrob Agents Chemother. 2016 Jan 19. pii: AAC.02002.
    PubMed     Text format     Abstract available


  59. KIP AE, Rosing H, Hillebrand MJ, Blesson S, et al
    Validation and clinical evaluation of a novel method to measure miltefosine in leishmaniasis patients using dried blood spot sample collection.
    Antimicrob Agents Chemother. 2016 Jan 19. pii: AAC.02976.
    PubMed     Text format     Abstract available


  60. AL-QAHTANI A, Alkahtani S, Kolli B, Tripathi P, et al
    Amino-phthalocyanine-mediated photodynamic inactivation of Leishmania tropica.
    Antimicrob Agents Chemother. 2016 Jan 11. pii: AAC.01879.
    PubMed     Text format     Abstract available


  61. CAUCHARD S, Van Reet N, Buscher P, Goux D, et al
    Killing of Trypanozoon parasites by the equine cathelicidin eCATH1.
    Antimicrob Agents Chemother. 2016 Jan 11. pii: AAC.01127.
    PubMed     Text format     Abstract available


    December 2015
  62. GREEN JL, Moon RW, Whalley D, Bowyer PW, et al
    Imidazopyridazine inhibitors of Plasmodium falciparum calcium dependent protein kinase 1 also target cGMP-dependent protein kinase and heat shock protein 90 to kill the parasite at different stages of intracellular development.
    Antimicrob Agents Chemother. 2015 Dec 28. pii: AAC.01748.
    PubMed     Text format     Abstract available


  63. MARON MI, Magle CT, Czesny B, Turturice BA, et al
    Maduramicin rapidly eliminates malaria parasites and potentiates the gametocytocidal activity of the pyrazoleamide, PA21A050.
    Antimicrob Agents Chemother. 2015 Dec 28. pii: AAC.01928.
    PubMed     Text format     Abstract available


  64. SAUNDERS DL, Chaorattanakawee S, Gosi P, Lanteri C, et al
    Atovaquone-proguanil remains a potential stop-gap therapy in areas of multidrug resistant P. falciparum on the Thai-Cambodian border.
    Antimicrob Agents Chemother. 2015 Dec 28. pii: AAC.02302.
    PubMed     Text format     Abstract available


  65. MCCALLUM F, Harris I, van Breda K, De SL, et al
    Evaluation of the 2-aminomethylphenol, JPC-2997 in Aotus Monkeys Infected with Plasmodium falciparum.
    Antimicrob Agents Chemother. 2015 Dec 14. pii: AAC.02799.
    PubMed     Text format     Abstract available


  66. NYUNT MM, Nguyen VK, Kajubi R, Huang L, et al
    Artemether-Lumefantrine Pharmacokinetics and Clinical Response is Minimally Altered in Ugandan Pregnant Women Treated for Uncomplicated Plasmodium Falciparum Malaria.
    Antimicrob Agents Chemother. 2015 Dec 14. pii: AAC.01605.
    PubMed     Text format     Abstract available


  67. RAJENDRAN V, Rohra S, Raza M, Hasan GM, et al
    Stearylamine Liposomal Delivery of Monensin in combination with free Artemisinin eliminates blood stages of P. falciparum in culture and P. berghei infection in Murine Malaria.
    Antimicrob Agents Chemother. 2015 Dec 14. pii: AAC.01796.
    PubMed     Text format     Abstract available


    October 2015
  68. WANG W, Qin Z, Zhu D, Wei Y, et al
    Synthesis, bioactivity evaluation and toxicity assessment of novel salicylanilide ester derivatives as cercaricides against Schistosoma japonicum and molluscicides against Oncomelania hupensis.
    Antimicrob Agents Chemother. 2015 Oct 26. pii: AAC.01539.
    PubMed     Text format     Abstract available


  69. BOUSSAROQUE A, Fall B, Madamet M, Camara C, et al
    Emergence of mutations in the K13 Propeller gene of Plasmodium falciparum isolates from Dakar, Senegal in 2013-2014.
    Antimicrob Agents Chemother. 2015 Oct 26. pii: AAC.01346.
    PubMed     Text format     Abstract available


  70. BRUSSEE JM, Yeo TW, Lampah DA, Anstey NM, et al
    A pharmacokinetic-pharmacodynamic model for the effect of l-arginine on endothelial function in patients with moderately severe falciparum malaria.
    Antimicrob Agents Chemother. 2015 Oct 19. pii: AAC.01479.
    PubMed     Text format     Abstract available


  71. EDAYE S, Tazoo D, Bohle DS, Georges E, et al
    3-halo Chloroquine Derivatives Overcome PfCRT-mediated Drug Resistance in Plasmodium falciparum.
    Antimicrob Agents Chemother. 2015 Oct 5. pii: AAC.01139.
    PubMed     Text format     Abstract available


    September 2015
  72. CABRERA M, Cui L
    In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum.
    Antimicrob Agents Chemother. 2015 Sep 28. pii: AAC.01948.
    PubMed     Text format     Abstract available


  73. TORRENTINO-MADAMET M, Collet L, Lepere JF, Benoit N, et al
    Plasmodium falciparum K13-Propeller Polymorphisms Isolated from Patients in Mayotte in 2013-2014.
    Antimicrob Agents Chemother. 2015 Sep 28. pii: AAC.01251.
    PubMed     Text format     Abstract available


  74. LUCCHI NW, Komino F, Okoth SA, Goldman I, et al
    In vitro and molecular surveillance for antimalarial drug resistance in Plasmodium falciparum parasites in western Kenya reveals sustained artemisinin sensitivity and increased chloroquine sensitivity.
    Antimicrob Agents Chemother. 2015 Sep 21. pii: AAC.01894.
    PubMed     Text format     Abstract available


  75. DAS M, Saha G, Saikia AK, Dubey VK, et al
    Novel leads against miltefosine-unresponsive Leishmania donovani.
    Antimicrob Agents Chemother. 2015 Sep 21. pii: AAC.00928.
    PubMed     Text format     Abstract available


    August 2015
  76. BENDEL D, Rulisa S, Ansah P, Sirima S, et al
    Efficacy of a novel sublingual spray formulation of artemether in African children with falciparum malaria.
    Antimicrob Agents Chemother. 2015 Aug 24. pii: AAC.00243.
    PubMed     Text format     Abstract available


  77. HASTINGS IM, Kay K, Hodel EM
    How robust are malaria parasite clearance rates as indicators of drug effectiveness and resistance?
    Antimicrob Agents Chemother. 2015 Aug 3. pii: AAC.00481.
    PubMed     Text format     Abstract available


  78. KLOPROGGE F, McGready R, Hanpithakpong W, Blessborn D, et al
    Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border.
    Antimicrob Agents Chemother. 2015 Aug 3. pii: AAC.00267.
    PubMed     Text format     Abstract available


  79. MACEDO-SILVA ST, Visbal G, Urbina JA, de Souza W, et al
    Potent in vitro antiproliferative synergism of combinations of ergosterol biosynthesis inhibitors against Leishmania amazonensis.
    Antimicrob Agents Chemother. 2015 Aug 3. pii: AAC.01150.
    PubMed     Text format     Abstract available


    July 2015
  80. WIRJANATA G, Sebayang BF, Chalfein F, Prayoga, et al
    Potent ex vivo activity of naphthoquine and methylene blue against drug resistant clinical isolates of Plasmodium falciparum and Plasmodium vivax.
    Antimicrob Agents Chemother. 2015 Jul 20. pii: AAC.00874.
    PubMed     Text format     Abstract available


  81. MONTOYA A, Daza A, Munoz D, Rios K, et al
    Development of novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy: in vitro and in vivo studies.
    Antimicrob Agents Chemother. 2015 Jul 13. pii: AAC.00545.
    PubMed     Text format     Abstract available


  82. FERNANDEZ-RUBIO C, Campbell D, Vacas A, Ibanez E, et al
    Exploring Leishmanicidal Activities of Novel Methylseleno Imidocarbamates.
    Antimicrob Agents Chemother. 2015 Jul 6. pii: AAC.00997.
    PubMed     Text format     Abstract available


  83. WIRJANATA G, Sebayang BF, Chalfein F, Prayoga, et al
    Contrasting ex vivo efficacy of "reversed chloroquine" compounds in chloroquine resistant Plasmodium falciparum and P. vivax isolates.
    Antimicrob Agents Chemother. 2015 Jul 6. pii: AAC.01048.
    PubMed     Text format     Abstract available


    June 2015
  84. MBONYE AK, Birungi J, Yanow SK, Shokoples S, et al
    The prevalence of P. falciparum resistance markers to sulphadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment of malaria in Uganda.
    Antimicrob Agents Chemother. 2015 Jun 29. pii: AAC.00507.
    PubMed     Text format     Abstract available


  85. GAILLARD T, Sriprawat K, Briolant S, Wangsing C, et al
    Molecular Markers and In Vitro Susceptibility to Doxycycline in Plasmodium falciparum Isolates from Thailand.
    Antimicrob Agents Chemother. 2015 Jun 8. pii: AAC.00345.
    PubMed     Text format     Abstract available


  86. SEIFERT K, Juhls C, Salguero FJ, Croft SL, et al
    Sequential chemo-immunotherapy of experimental visceral leishmaniasis using single low dose liposomal amphotericin B and a novel DNA vaccine candidate.
    Antimicrob Agents Chemother. 2015 Jun 8. pii: AAC.00273.
    PubMed     Text format     Abstract available


  87. ROMERO I, Tellez J, Romanha AJ, Steindel M, et al
    Up regulation of Cysteine Synthase (CS) and Cystathionine beta-Synthase (CbetaS) contributes to Leishmania braziliensis survival under oxidative stress.
    Antimicrob Agents Chemother. 2015 Jun 1. pii: AAC.04880.
    PubMed     Text format     Abstract available


  88. COOPER RA, Conrad MD, Watson QD, Huezo SJ, et al
    Lack of artemisinin resistance in Plasmodium falciparum in Uganda based on parasitological and molecular assays.
    Antimicrob Agents Chemother. 2015 Jun 1. pii: AAC.00921.
    PubMed     Text format     Abstract available


  89. ZAHIR AA, Chauhan IS, Bagavan A, Kamaraj C, et al
    Green synthesis of silver and titanium dioxide nanoparticles using Euphorbia prostrata extract showed shift from apoptosis to G0/G1 arrest followed by necrotic cell death in Leishmania donovani.
    Antimicrob Agents Chemother. 2015 Jun 1. pii: AAC.00098.
    PubMed     Text format     Abstract available


    May 2015
  90. HENDRICKX S, Mondelaers A, Eberhardt E, Delputte P, et al
    In vivo selection of paromomycin and miltefosine resistance in Leishmania donovani and L. infantum in the Syrian hamster model.
    Antimicrob Agents Chemother. 2015 May 26. pii: AAC.00707.
    PubMed     Text format     Abstract available


  91. BASSAT Q, Ogutu B, Djimde A, Stricker K, et al
    Tailoring formulations to patients in need: Experience with the paediatric formulation of artemether-lumefantrine (Coartem(R) Dispersible) for the treatment of P. falciparum malaria.
    Antimicrob Agents Chemother. 2015 May 26. pii: AAC.00014.
    PubMed     Text format     Abstract available


  92. LEANG R, Taylor WR, Bouth DM, Song L, et al
    Evidence of falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment.
    Antimicrob Agents Chemother. 2015 May 26. pii: AAC.00835.
    PubMed     Text format     Abstract available


  93. CORTES S, Albuquerque A, Cabral LI, Lopes L, et al
    In vitro susceptibility of Leishmania infantum to Artemisinin derivatives and selected trioxolanes.
    Antimicrob Agents Chemother. 2015 May 26. pii: AAC.00298.
    PubMed     Text format     Abstract available


  94. CHAORATTANAKAWEE S, Saunders DL, Sea D, Chanarat N, et al
    Ex vivo drug susceptibility and molecular profiling of clinical Plasmodium falciparum isolates from Cambodia in 2008-2013 suggest emerging piperaquine resistance.
    Antimicrob Agents Chemother. 2015 May 26. pii: AAC.00366.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: